相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment
Francesca D'Avanzo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
Carolin Heller et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms
Gustavo M. Viana et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations
Rossella Parini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys
Mihalis S. Kariolis et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice
Julie C. Ullman et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Longitudinal biomarkers in amyotrophic lateral sclerosis
Fen Huang et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
NFL is a marker of treatment response in children with SMA treated with nusinersen
Bob Olsson et al.
JOURNAL OF NEUROLOGY (2019)
Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS
Shaochun Zhu et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2019)
The role of innate immunity in mucopolysaccharide diseases
Helen Parker et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial
Torayuki Okuyama et al.
MOLECULAR THERAPY (2019)
Neurofilament light is a treatment-responsive biomarker in CLN2 disease
Yuanbin Ru et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Biomarkers in patients with mucopolysaccharidosis type II and IV
Honoka Fujitsuka et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2019)
Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion
Michael Benatar et al.
ANNALS OF NEUROLOGY (2018)
Development and validation of an LC-MS/MS Method for the quantitation of heparan sulfate in human urine
Kai Wang et al.
BIOMEDICAL CHROMATOGRAPHY (2018)
Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms
Helene F. E. Gleitz et al.
EMBO MOLECULAR MEDICINE (2018)
Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison
Julie B. Eisengart et al.
GENETICS IN MEDICINE (2018)
A novel LC-MS/MS assay to quantify dermatan sulfate in cerebrospinal fluid as a biomarker for mucopolysaccharidosis II
Peng Pan et al.
BIOANALYSIS (2018)
CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration
Marc Pawlitzki et al.
FRONTIERS IN NEUROLOGY (2018)
Subregional brain distribution of simple and complex glycosphingolipids in the mucopolysaccharidosis type I (Hurler syndrome) mouse: impact of diet
Jennifer T. Saville et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Treatment of brain disease in the mucopolysaccharidoses
Maurizio Scarpa et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II
Francyne Kubaski et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Correlation of CSF flow using phase-contrast MRI with ventriculomegaly and CSF opening pressure in mucopolysaccharidoses
Amauri Dalla Corte et al.
FLUIDS AND BARRIERS OF THE CNS (2017)
A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II
Joseph Muenzer et al.
GENETICS IN MEDICINE (2016)
Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration
Aiko Ishiki et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Oxidative and nitrative stress and pro-inflammatory cytokines in Mucopolysaccharidosis type II patients: effect of long-term enzyme replacement therapy and relation with glycosaminoglycan accumulation
Carlos Eduardo Diaz Jacques et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
Mehtap Bacioglu et al.
NEURON (2016)
Elevated cerebral spinal fluid biomarkers in children with mucopolysaccharidosis I-H
Gerald V. Raymond et al.
SCIENTIFIC REPORTS (2016)
Serum ubiquitin C-terminal hydrolase L1 as a biomarker for traumatic brain injury: a systematic review and meta-analysis
Jian Li et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2015)
Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and Hunter syndrome patients with and without cognitive impairment
Christian J. Hendriksz et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2015)
High-dose enzyme replacement therapy attenuates cerebroventriculomegaly in a mouse model of mucopolysaccharidosis type II
So Yoon Ahn et al.
JOURNAL OF HUMAN GENETICS (2013)
Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
Fiona L. Wilkinson et al.
PLOS ONE (2012)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Metabolic Pathways and Intracellular Trafficking of Gangliosides
Jose Luis Daniotti et al.
IUBMB LIFE (2011)
Biological Function of the Cellular Lipid BMP-BMP as a Key Activator for Cholesterol Sorting and Membrane Digestion
Hichem D. Gallala et al.
NEUROCHEMICAL RESEARCH (2011)
Transplant Outcomes in Mucopolysaccharidoses
Vinod K. Prasad et al.
SEMINARS IN HEMATOLOGY (2010)
IDS Crossing of the Blood-Brain Barrier Corrects CNS Defects in MPSII Mice
Vinicia Assunta Polito et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Secondary lipid accumulation in lysosomal disease
Steven U. Walkley et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Principles of lysosomal membrane degradation Cellular topology and biochemistry of lysosomal lipid degradation
Heike Schulze et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Recognition and diagnosis of Mucopolysaccharidosis II (Hunter syndrome)
Rick Martin et al.
PEDIATRICS (2008)
Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue
Kimiko Hamano et al.
ACTA NEUROPATHOLOGICA (2008)
Secondary accumulation of gangliosides in lysosomal storage disorders
SU Walkley
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
分享论文
